Healthcare Pharmaceutical Biotech

Action Behavior Centers Joins the Eagles Autism Challenge as Proud Partner, Hosts Sensory Kids Zone in Philadelphia

May 13, 2026 6:15 PM

Action Behavior Centers (ABC), a leading provider of evidence-based applied behavior analysis (ABA) therapy for children diagnosed with autism spectrum disorder (ASD), served as the Proud Partner of the 2026 Eagles Autism Challenge (EAC) on May 9 in Philadelphia. As part of the partnership, ABC hosted the Sensory Kids Zone, a calmer, quieter space designed to help families with young autistic children feel comfortable and included during the...

Read more

Purisaki Berberine Patches Reviews and Complaints 2026: What to Verify Before Ordering - Third-Party Feedback, Ingredient Evidence Gaps, Pricing, and Refund Terms

May 13, 2026 4:45 PM

Disclosure: This article is a paid advertorial-style consumer analysis and contains affiliate links. If a purchase is made through links in this article, a commission may be earned at no additional cost to the buyer. This article is for informational purposes only and is not medical advice. Purisaki Berberine Patches are marketed by the brand as topical botanical wellness patches containing berberine and other botanical ingredients. These...

Read more

Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the First Quarter 2026

May 13, 2026 4:05 PM

Dermata Therapeutics, Inc. (Nasdaq:DRMA, DRMAW) ("Dermata," or the "Company"), a science-driven leader in dermatologic solutions, today highlighted recent corporate progress and reported financial results for the first quarter ended March 31, 2026. "Since announcing our strategic pivot in September 2025, we have made meaningful progress toward becoming a direct-to-consumer commercial skincare company," commented Gerry Proehl, Dermata's Chairman,...

Read more

Aytu BioPharma Reports Fiscal 2026 Third Quarter Operational and Financial Results

May 13, 2026 4:05 PM

Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on advancing innovative medicines for complex central nervous system diseases to improve the quality of life for patients, today announced operational and financial results for the fiscal 2026 third quarter. Q3 Fiscal 2026 Highlights Net revenue of $12.4 million versus $18.5 million in Q3 fiscal 2025. EXXUA net revenue was $2.4 million during Q3 fiscal...

Read more

Congress Orders DEA Crackdown on Intoxicating Cannabinoids While CMS Continues Expanding Medicare CBD Access

May 13, 2026 12:10 PM

The federal government is now simultaneously expanding cannabinoid access inside Medicare connected healthcare systems while directing federal law enforcement agencies to crack down on cannabinoid products that "threaten consumer safety." That contradiction now sits directly before a federal court in Washington. On one side, the Centers for Medicare & Medicaid Services continues advancing the Substance Access Beneficiary Engagement Incentive...

Read more

AGFA HealthCare Signals Strong Start to 2026 with Enterprise Imaging Go-Live Momentum and Continued KLAS Leadership

May 13, 2026 12:00 PM

AGFA HealthCare, a leading provider of Enterprise Imaging solutions, announced a strong start to 2026, driven by multiple successful go-lives across North America and continued top-tier recognition from KLAS Research, reinforcing its leadership in a rapidly evolving imaging IT landscape. As healthcare organizations increasingly prioritize platform consolidation and cloud-enabled scalability, AGFA HealthCare continues to execute on complex...

Read more

Emergency Care Partners Secures 'Best Places to Work' Honor for Fourth Consecutive Year

May 13, 2026 10:30 AM

Modern Healthcare has selected Emergency Care Partners (ECP) as one of the 2026 Best Places to Work in Healthcare. The complete list of this year's winners, in alphabetical order, is available at ModernHealthcare.com/bestplaceslist. Modern Healthcare will publish a special supplement featuring a ranked list of all the winners with the October issue of MH magazine. "Healthcare is changing rapidly as new technologies are adopted on both the...

Read more

Queue Ventures Receives Final Order Approving Previously Announced Plan of Arrangement with Custom Health, Inc.

May 13, 2026 10:00 AM

Queue Ventures Ltd. ("Queue" or the "Company") is pleased to announce, further to its press release dated May 7, 2026, it has been granted the final order (the "Final Order") from the Supreme Court of British Columbia approving the Company's previously announced plan of arrangement (the "Arrangement") with Custom Health, Inc. ("Custom Health"). Receipt of the Final Order follows approval of the Arrangement by shareholders of Queue at its annual...

Read more

N-Zyme Biomedical Applauds FDA's Newly Announced Initiatives Supporting Drug Repurposing for Unmet Medical Needs

May 13, 2026 9:33 AM

N-Zyme Biomedical, a clinical-stage biopharmaceutical company focused on developing innovative therapies for reflux disease, today expressed strong support for the U.S. Food and Drug Administration's newly announced initiatives aimed at advancing drug repurposing to help address significant unmet medical needs. The FDA announcement highlights the agency's continued interest in leveraging existing scientific and safety data associated with...

Read more

Wellgistics Health Announces Pilot MSO Collaboration with Kare PharmTech Targeting $14 Billion U.S. Market for CCM and RPM Services

May 13, 2026 9:05 AM

Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics" or the "Company"), a leading healthcare technology and pharmaceutical distribution company, today announced a pilot collaboration with Kare PharmTech and Kare Clinicals integrating its MSO infrastructure to support chronic care management ("CCM") and remote patient monitoring ("RPM") services across participating provider offices. According to third-party industry reports, the U.S. RPM market...

Read more

What's for Dinner? MDCE's Snapshot Recipes Uses AI to Transform Ingredient Photos Into Instant Recipes

May 13, 2026 9:01 AM

Medical Care Technologies Inc. (OTC PINK:MDCE) today announced growing early momentum for its AI-powered mobile application, Snapshot Recipes (www.snapshotrecipes.app), a next-generation recipe discovery platform designed to help consumers create meals instantly from ingredients they already have at home. Before launching a formal user-generated content (UGC) influencer campaign, Snapshot Recipes has already surpassed key early milestones,...

Read more

TRNR to Report Q1 2026 Results on May 20, 2026; Previews Preliminary Q1 Pro Forma Revenue of Approximately $7.7 Million

May 13, 2026 9:00 AM

Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of innovative specialty fitness equipment under the Wattbike, CLMBR, FORME and Ergatta brands, today announced that it expects to report its first quarter 2026 financial results on May 20, 2026, due to additional time required to incorporate the financials of the most recent acquisition, Ergatta. In connection with today's announcement, the Company is providing a...

Read more

HealthJoy Moves Beyond Navigation to One End-to-End Benefits Operating System

May 13, 2026 9:00 AM

HealthJoy, a benefits operating system for employers, today announced new capabilities that signal the company's evolution from a benefits navigation platform to an AI-driven benefits operating system spanning the member's full health decision journey. The capabilities, part of a broader platform rollout, aim to bridge the gap between the benefits plans brokers and employers design and the decisions members make across the calendar year, from...

Read more

Dr. Rubinstein Offers Expanded Facial Rejuvenation Options in Montvale, NJ and Newburgh, NY as FDA Approves Restylane(R) Contour for Temple Hollowing

May 13, 2026 9:00 AM

Galderma has announced that the FDA has approved Restylane® Contour for the correction of temple hollowing in patients over the age of 21, adding a new indication to one of the most clinically versatile fillers in the Restylane portfolio. Rubinstein Plastic Surgery Center in Montvale, NJ and Laser & Cosmetic Surgery Specialists in Newburgh, NY - both led by double board-certified facial plastic surgeon Ran Y. Rubinstein, MD - offer Restylane...

Read more

The Ridge RTC Maine Highlights the Role of Equine-Assisted Therapy in Its Commitment to Experiential Healing for Adolescents

May 13, 2026 9:00 AM

The Ridge RTC, a leading residential mental health treatment center for adolescents, today highlighted the role of equine-assisted therapy at its mid-coast Maine campus. The program integrates equine-assisted therapeutic experiences directly into the clinical treatment model for teens ages 12 to 17, offering a nature-based, relational therapeutic modality shown to be effective for youth struggling with trauma, anxiety, depression, and emotional...

Read more

CVS Health Wins Gold in Enterprise AI, and Silver in Customer Experience AI at 2026 Stevie(R) (American Business Awards(R)) for Enterprise Scale AI Innovation

May 13, 2026 9:00 AM

Originally published on CVS Health Company News CVS Health® (NYSE:CVS) announced it has been named a Gold winner in Enterprise AI and Silver in Customer Experience AI categories at the 2026 Stevie® Awards (American Business Awards®), one of the most prestigious and rigorously judged business awards programs in the United States. The American Business Awards AI categories recognize production grade AI systems operating at enterprise scale,...

Read more

Military Compression, a Division of 1 Natural Way, Rebrands to Go Strong Supply, Launches New Medical-Grade Custom Boot Orthotics

May 13, 2026 8:30 AM

1 Natural Way, a nationally recognized Durable Medical Equipment (DME) provider, today announced the rebrand of its Military Compression division to Go Strong Supply and the launch of medical-grade custom boot orthotics developed specifically for active-duty service members. The rebrand reflects the company's broader mission to support the physical demands placed on active-duty personnel through medically aligned products designed for military...

Read more

Aptevo Therapeutics Provides a 1Q26 Business Update; RAINIER on Track for 2026 Completion and Phase 2 Dose Selection

May 13, 2026 8:05 AM

Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR™ and ADAPTIR-FLEX™ platform technologies, today provided a business update. "Aptevo is entering a defining period as a company, supported by growing clinical momentum, a committed leadership team, and a pipeline with the potential to create significant long-term value," said Jeff...

Read more

MIRA Pharmaceuticals Announces Acceptance of Peer-Reviewed SKNY-1 Manuscript Highlighting Oral Obesity and Nicotine Addiction Drug Candidate

May 13, 2026 8:00 AM

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) ("MIRA" or the "Company"), a clinical-stage pharmaceutical company focused on the development of investigational therapeutics for neurologic, neuropsychiatric, and metabolic disorders, today announced the acceptance and publication of a peer-reviewed manuscript describing the preclinical pharmacology and activity of SKNY-1, the Company's oral investigational drug candidate being evaluated for obesity and...

Read more

Becker's Hospital Review Names Todd Suntrapak Among 2026's Top Rural Health System CEOs

May 13, 2026 7:15 AM

Todd Suntrapak, president and CEO of Valley Children's Healthcare, has been featured on Becker's Hospital Review's 2026 list of 146 rural hospital and health system presidents and CEOs to know. The annual roster spotlights executives whose work is broadening care access, building stronger clinical workforces and reinforcing the economic foundations of the communities their organizations serve. According to Becker's, the executives on this...

Read more